1-6 of 6
Amanda Copeland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Experience with obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma

Yasuhiro Oki, Amanda Copeland, Fredrick Hagemeister, Luis E. Fayad, Michelle Fanale, Jorge Romaguera, Anas Younes
Journal: Blood
Blood (2012) 119 (9): 2171–2172.
https://doi.org/10.1182/blood-2011-11-391037
Published: 2012
Journal Articles

Improving T Cell Therapy for Relapsed EBV-Negative Hodgkin's Lymphoma by Targeting Upregulated MAGE-A4

Conrad Russell Y. Cruz, MD, Ulrike Gerdemann, MD, Ann M. Leen, PhD, Jessica A. Shafer, MD, Stephanie Ku, BS, Benjamin Tzou, BS, Terzah M. Horton, MD, PhD, Amanda Copeland, MSN, Anas Younes, MD, Cliona M. Rooney, PhD, Helen E. Heslop, MD, Catherine M. Bollard, MD
Journal: Blood
Blood (2011) 118 (21): 1658.
https://doi.org/10.1182/blood.V118.21.1658.1658
Published: 2011
Journal Articles

Safety and Efficacy of the Novel Combination of Panobinostat (LBH589) and Everolimus (RAD001) in Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma,

Anas Younes, MD, Amanda Copeland, MSN, Michelle A. Fanale, MD, Luis Fayad, MD, Jorge E Romaguera, MD, Larry W Kwak, MD, PhD, Sattva S. Neelapu, MD, Fredrick Hagemeister, MD, Barbara Pro, MD, Silvana de Castro Faria, MD, Yuan Ji, PhD, Donald Berry, Daniela Buglio, MD, PhD, L. Jeffrey Medeiros, MD
Journal: Blood
Blood (2011) 118 (21): 3718.
https://doi.org/10.1182/blood.V118.21.3718.3718
Published: 2011
Journal Articles

ENGAGE- 501: Phase 2 Study Investigating the Role of Epigenetic Therapy with Entinostat (SNDX-275) In Relapsed and Refractory Hodgkin's Lymphoma (HL), Interim Results

Anas Younes, MD, Francisco Hernandez, R. Gregory Bociek, MD, Yvette L. Kasamon, Peter Lee, MD, PhD, Lia Gore, MD, Daniela Buglio, MD, PhD, Amanda Copeland
Journal: Blood
Blood (2010) 116 (21): 3959.
https://doi.org/10.1182/blood.V116.21.3959.3959
Published: 2010
Journal Articles

Phase I/II Study of the Novel Combination of Panobinostat (LBH589) and Everolimus (RAD001) In Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma

Anas Younes, MD, Amanda Copeland, MSN, Michelle A. Fanale, MD, Fredrick Hagemeister, MD, Luis Fayad, MD, Barbara Pro, MD, Silvana C. Faria, MD, PhD, Yuan Ji, PhD, L. Jeffrey Medeiros, MD, Donald A Berry, PhD, Daniela Buglio, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3964.
https://doi.org/10.1182/blood.V116.21.3964.3964
Published: 2010
Journal Articles

Phase I Study of a Novel Oral JAK-2 Inhibitor SB1518 In Patients with Relapsed Lymphoma: Evidence of Clinical and Biologic Activity In Multiple Lymphoma Subtypes.

Anas Younes, MD, Michelle A. Fanale, MD, Peter McLaughlin, MD, Amanda Copeland, Joy Zhu, Silvania de Castro Faria
Journal: Blood
Blood (2010) 116 (21): 2830.
https://doi.org/10.1182/blood.V116.21.2830.2830
Published: 2010